Topic: John Wallingford

Common Antifungal Drug Decreases Tumor Growth and Shows Promise as Cancer Therapy

Aug. 21, 2012

An inexpensive antifungal drug, thiabendazole, slows tumor growth and shows promise as a chemotherapy for cancer. Scientists in the College of Natural Sciences at The University of Texas at Austin made this discovery by exploiting the evolutionary relatedness of yeast, frogs, mice and humans.

Read more

Research of Cell Movements in Developing Frogs Reveals New Twists in Human Genetic Disease

July 30, 2010

Mutations in a gene known as "Fritz" may be responsible for causing human genetic disorders such as Bardet-Biedl syndrome, University of Texas at Austin developmental biologist John Wallingford and Duke University human geneticist and cell biologist Nicholas Katsanis have found.

Read more

Getting Started: Biologist John Wallingford

July 6, 2010
Getting Started: Biologist John Wallingford

John Wallingford, associate professor in the Section of Molecular Cell and Developmental Biology, said his early interest in science was nurtured by a teacher. "Alice Kagi," he said. "She was just fantastic. She was so enthusiastic and so excited."

Read more

In the Know

May 4, 2010
In the Know

The May 4 weekly roundup of campus kudos and press mentions.

Read more

Scientists Find New Genes for Cancer, Other Diseases in Plants, Yeast and Worms

April 13, 2010

From deep within the genomes of organisms as diverse as plants, worms and yeast, scientists have uncovered new genes responsible for causing human diseases such as cancer and deafness.

Read more